Amarin Corp Stock (NASDAQ: AMRN) stock price, news, charts, stock research, profile.
Open | $0.980 |
Close | $0.975 |
Volume / Avg. | 648.108K / 1.529M |
Day Range | 0.957 - 1.030 |
52 Wk Range | 0.651 - 1.485 |
Market Cap | $390.325M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 53 |
Short Interest | 3.9% |
Days to Cover | 10.15 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Amarin Corp (NASDAQ: AMRN) through any online brokerage.
Other companies in Amarin Corp’s space includes: Skye Bioscience (NASDAQ:SKYE), Precigen (NASDAQ:PGEN), Replimune Group (NASDAQ:REPL), Anika Therapeutics (NASDAQ:ANIK) and Neurogene (NASDAQ:NGNE).
The latest price target for Amarin Corp (NASDAQ: AMRN) was reported by JP Morgan on Monday, November 20, 2023. The analyst firm set a price target for 0.00 expecting AMRN to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.
The stock price for Amarin Corp (NASDAQ: AMRN) is $0.95 last updated May 7, 2024 at 6:52 PM EDT.
There are no upcoming dividends for Amarin Corp.
Amarin Corp’s Q2 earnings are confirmed for Wednesday, July 31, 2024.
There is no upcoming split for Amarin Corp.
Amarin Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.